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Abstract
Purpose/Aims: The purpose of this descriptive, correlational, cross-sectional study was
to examine the relationships among perinatal mood and anxiety disorder (PMAD)
symptomatology, select demographics, stigma of mental illness, and social support,
among inpatient postpartum women.
Rationale: PMADs affect as many as 21% of childbearing women, yet these disorders
are identified and treated less than half the time. There is a gap in the literature regarding
the relationships among stigma, social support, and PMADs in postpartum women.
Conceptual Basis/Background: Despite recommendations from professional
organizations, screening for PMADs is not consistently completed using a valid, reliable
instrument. Stigma contributes to the low rate of identification and treatment. Extant
research shows an inverse relationship between high levels of social support and
PMADs, possibly mitigating the effects of stigma.
Findings: A sample of 105 participants was divided into a low risk group (Group A)
and a high-risk group (Group B) based on a score of >10 on the Edinburgh Postnatal
Depression Scale (EPDS) or the Generalized Anxiety Disorder 7-item (GAD-7)
screening instruments. There were significant differences between groups for marital
status (p=.01) with a higher percentage in Group A who were married and significant
differences between groups for stigma (p=.002), with higher stigma for Group B
participants. Social support measurements were also significantly different between
groups (p<.001), with higher social support in Group A. Current hospital screening for
depression and anxiety as well as thoughts of self-harm identified less patients at risk,
highlighting the need to further evaluate the existing screening process.

Implications: This study contributes to the nursing profession by highlighting the
prevalence of PMADs, impact on families, ongoing barriers to identification and
treatment, and highlights gaps in the existing hospital screening process as compared to
screening utilizing valid, reliable instruments and provides the basis for implementing
standardized screening in the inpatient setting.
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Chapter 1
Introduction
Perinatal mood and anxiety disorders (PMADs) constitute a global public health problem
affecting 10% of pregnant women and 13% of postpartum women worldwide (Mental Health,
n.d.). Although data are limited for low- and middle-income countries, rates have been reported
to be 2 to 3 times higher in countries with limited resources (United National Population Fund
[UNFPA], 2007). Prevalence in the United States is as high as 21% of childbearing women, yet
these disorders are identified and treated less than half the time (Wisner et al., 2013, Yawn et al.,
2012). With approximately 3.9 million women between the ages of 12 and 50 giving birth in the
United States each year, this equates to nearly 81,900 diagnosed with a PMAD and up to 41,000
left untreated (Facts for Features, 2017). There is a significant financial impact to society when
mothers suffer from PMADs. Using a pathway or decision modeling approach, Bauer, Knapp,
and Parsonage (2016) estimated the lifetime costs of depression and anxiety in the perinatal
period at 8,500 pounds per woman, 6.6 billion pounds annually in the United Kingdom, which is
equivalent to more than 8 billion United States dollars per year.
Background
Defining PMADs
Psychiatric disorders occurring during pregnancy and up to one year postpartum included
under the term PMADs are depression, anxiety, obsessive-compulsive disorder, post-traumatic
stress disorder, and psychosis (Gavin et al., 2005). Postpartum “blues” or “baby blues” are
experienced by as many as 70% of new mothers and may include symptoms such as crying,
irritability, and anxiety. Symptoms of postpartum blues generally last only one to two weeks and
resolve without treatment (American Psychiatric Association, 2013). Symptoms lasting more
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than several weeks may be attributable to PMADs (Langan & Goodbred, 2016; O'Hara &
Wisner, 2014; Schetter & Tanner, 2012).
Factors
The prevalence of PMADs vary in the literature with rates as high as 23%, yet only 16%
of those who screen positive receive treatment (Byatt, Biebel, Friedman, Debordes-Jackson, &
Ziedonis, 2013; Mayberry, Horowitz, & Declerq, 2007). There are multiple factors contributing
to the low rate of identification of mothers with PMADs. One factor is inadequate screening.
Several valid, reliable screening instruments are available including the Edinburgh Postnatal
Depression Scale (EPDS) which is available in multiple languages (Cox, Holden & Sagovsky,
1987). Anxiety and depression may exist as comorbid conditions; however, the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) does not have a distinct diagnosis
for perinatal anxiety, and symptoms of anxiety may be labeled as depression (American
Psychiatric Association, 2013). The use of additional screening instruments for anxiety have
been explored including the Edinburgh Postpartum Depression Scale -3A (Swalm et al., 2010)
and the Generalized Anxiety Disorder (GAD-7) (Spitzer, Kroenke, Williams, & Lowe, 2006), a
7-item scale specifically designed to measure anxiety symptoms. Screening for PMADs at least
once during the perinatal period using a standardized, validated instrument was recommended by
the American College of Obstetricians and Gynecologists (ACOG, 2015.) This opinion was
updated in November 2018 to include a recommendation that obstetric care providers not only
screen, but also complete a full assessment of the patient’s mood and emotional well-being at the
postpartum visit (ACOG, 2018). A 2019 policy statement from the American Academy of
Pediatrics (AAP) also recommends that screening be included in well-child visits (Earls,
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Yogman, Mattson & Rafferty, 2019). Screening may not be consistently completed, and if it is
completed using clinical judgment rather than with a standardized, validated instrument, health
care providers may not recognize symptoms (ACOG, 2018; Goodman & Tyler-Viola, 2010).
Stigma is a factor contributing to the low rate of identification of mothers with PMADs.
Stigma, or avoiding the label of mental illness, is one reason people choose not to pursue
treatment for mental health (Corrigan, 2004; Corrigan, Watson, Warpinski, & Gracia, 2004).
Dimensions of stigma have been described as internal/self, external/public, and disclosure
stigma, which may affect treatment-seeking behavior in different ways (Corrigan, 2004; Moore,
Ayers, & Drey, 2017). Internal stigma is when individuals attach stigma to their own identity.
External stigma is the stigma held by the general public. Disclosure stigma is the stigma
associated with disclosing symptoms and the expected discrimination associated with disclosure
(Moore et al., 2017). One aspect of stigma unique to the perinatal period is the external stigma
of being viewed as a bad mother and the internalization of that stigma (internal/self-stigma).
Depression can create a sense of failure and guilt further inhibiting mothers from disclosing
symptoms (Abrams & Curran, 2011).
While stigma may inhibit women from seeking treatment, social support may be a
positive mitigating factor. Higher levels of perceived stress are associated with increased risk of
depressive and anxiety symptoms, and higher perceived social support is associated with a
decreased risk for depressive symptoms. Interventions to increase social support may help to
improve maternal mental health (Schwab-Reese, Schafer & Ashida, 2017). Informal social
support from family and friends is associated with increased parental self-efficacy and decreased
depressive symptoms (Leahy-Warren, McCarthy, & Corcoran, 2011).
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Significance
In addition to affecting large groups of women, untreated PMADs affect the entire
family. Mothers may have difficulty concentrating and functioning, may feel hopeless or
anxious, may have sleep disturbances, may see changes in appetite and weight, and may become
suicidal (Miller, 2002; Schetter & Tanner, 2012). Mothers with PMADs face increased risks of
social isolation as a result of feelings of hopelessness (Letourneau et al., 2012). Women
experiencing postpartum psychosis have more severe mood disturbances, fluctuating between
mania and depression, and may experience delusions and hallucinations. The onset of
postpartum psychosis is often sudden, occurring in the first few weeks after delivery (Doucet,
Dennis, Letourneau, & Blackmore, 2009). Postpartum psychosis is less prevalent than perinatal
depression and anxiety, occurring in one to two cases for every 1,000 births (Munk-Olsen,
Laursen, Pedersen, Mors, & Mortensen, 2006).
Expectant and new fathers have an increased risk of depression; approximately 10% of
fathers experience depression during the postpartum period with the highest rates in the three to
six-month period. There is also an association between maternal and paternal depression
(Paulson & Bazemore, 2010). Infants and children of depressed parents are affected by PMADs.
Pregnancy-related anxiety is associated with negative birth outcomes including preterm birth,
which, in turn, increases the risk of infant mortality and can affect fetal neurodevelopment
(Doktorchik et al., 2017; Kramer et al., 2009; Schetter & Tanner, 2012). Parenting practices may
be adversely affected by PMADs; depressive symptoms in parents may be negatively associated
with positive interactions among parents and infants (Paulson, Dauber & Lieferman, 2006).
Maternal depression can negatively affect children’s social and emotional development (Junge et
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al., 2016). The effects of parental depression can last into young adulthood with a higher risk of
depression at age 18 when parents were depressed during the postpartum period (GutierrezGalve et al., 2018).
Qualitative research has identified stigma as a common barrier to treatment-seeking for
women with postpartum depression (Byatt et al., 2013). There is evidence in the literature
supporting the inverse relationship between social support and depressive symptoms; however,
there is a gap in the literature regarding the relationships between PMADs, stigma, and social
support among postpartum women.
Study Purpose and Aims
The purpose of this descriptive, correlational, cross-sectional study was to examine the
relationships among PMAD symptomatology, select demographics, stigma of mental illness, and
levels of social support, among inpatient postpartum women.
Research Question 1: Is there a relationship between stigma and PMAD
symptomatology?
Research Question 2: Are there differences in the type of stigma (external, internal, and
disclosure) and PMAD symptomatology, social support, and demographic factors such as age,
race/ethnicity, and pregnancy intent?
Research Question 3: What percentage of participants with PMAD symptomatology seek
treatment after discharge?
Research Question 4: What is the level of agreement between the current admission
screen and the interview screen using the EPDS and GAD-7?
The research questions were addressed through the following aims:
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Aim 1. Characterize a sample of inpatient postpartum women participating in mother-infant dyad
care.
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support, and
select demographics within a sample of inpatient postpartum women.
Aim 3. Assess treatment-seeking in women with PMAD symptomatology after discharge from
the hospital.
Conceptual Framework
Known risk factors for PMADs include a previous history of depression or anxiety and
sociodemographic factors, such as low income and unemployment; nonetheless, further study is
needed to identify if racial and ethnic factors play a role in the prevalence of PMAD separately
from socioeconomic factors (Liu & Tronick, 2013; Mayberry et al., 2007). When a mother
experiences a PMAD whether she has depression, anxiety, obsessive-compulsive disorder, posttraumatic stress disorder or a combination thereof, stigma can create a barrier to identification
and treatment. Stigma can be internal/self-stigma, external/public stigma, disclosure stigma, or a
combination of the categories (Corrigan, 2004). Erving Goffman’s (1963) concepts of stigma,
Patrick Corrigan’s (2004) concepts of public stigma and self-stigma, and Moore and colleagues’
(2017) concepts of internal, external, and disclosure stigma will provide underpinnings for this
research. In addition, the work of Zimet, Dahlem, Simet, and Farley (1988) in developing the
Multidimensional Scale of Perceived Social Support Scale (MSPSS) will provide the basis for
examining the role of social support in potentially mitigating the stigma of mental illness. High
levels of social support are inversely correlated with depressive symptoms and may help to
mitigate the stigma of mental illness (Webster, Nicholas, Velacott, Cridland, & Fawcett, 2011).
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The inverse relationship between high levels of social support on depressive symptoms has been
documented in the literature; however, there is a gap in the literature regarding the relationships
among PMADs, stigma, and social support. This study will help to clarify these relationships
and the decision to seek treatment in a diverse sample of postpartum women (See Figure 1).
Understanding the inter-relationships among these variables will facilitate understanding of how
to mitigate the effects of stigma.
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Risk Factors
Previous History
Socioeconomic Factors

PMAD
Depression
Anxiety
Obsessive-compulsive disorder (OCD)
Post-traumatic stress disorder (PTSD)
Psychosis

Treatment

Figure 1: Research Conceptual Framework
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Chapter 2
Review of Literature
Prevalence
The prevalence of PMADs vary in the literature as a result of differences in the timing of
screening, instrument used, and cut point selected to classify depressive disorders. A large,
national cross-sectional study was conducted to review the differences in rates and severity of
depressive symptoms in four postpartum cohorts (0-6 months, 7-12 months, 13-18 months, and
19-24 months) using the EPDS. Mild depression ranged from 11%-15.1%, with no statistically
significant difference across the cohorts. Moderate to severe depression ranged from 17.1-23.1%
(Mayberry et al., 2007).
A 2013 period prevalence study of 10,000 postpartum women was conducted to examine
the timing of onset, prevalence, intensity of self-harm ideation, and specific primary and
secondary PMAD disorders. Mothers were screened during the hospital stay using the EPDS,
and home visits were completed for 826 women with a score of 10 or higher on the EPDS for a
diagnostic assessment. Depression was identified in 21.9% of participants in the first year
postpartum; 66.1% of patients diagnosed with PMADs had a comorbid diagnosis of depression
and anxiety and 5.6% had a primary diagnosis of anxiety disorder. Bipolar disorder was
diagnosed in 22.6% of patients with depressive symptoms, which is significant because patients
with bipolar disorder may be misdiagnosed with unipolar depression and improperly treated
(Wisner et al., 2013). Strengths of this study include the large, heterogeneous sample, psychiatric
diagnosis through home visits, analysis of the onset of symptoms, and the breakdown of
psychiatric diagnoses. Prevalence was not obtained for women with postpartum psychosis in this
study presumably because it is less common. Postpartum psychosis occurs in approximately 1-2
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cases per 1,000 births and is generally seen in the first couple of weeks after delivery, coinciding
with hormonal changes. Women with a history of bipolar disorder or a family history of bipolar
disorder are at increased risk for developing postpartum psychosis (Sit, Rothschild, & Wisner,
2006).
Etiology and Risk Factors
The etiology of PMADs is multi-faceted and not well-understood. Genetic, biological,
and environmental factors have been associated with PMADs. In a review of 17,912 phenotype
records aggregated from a 19-country psychiatry consortium, latent class analyses were applied
with two tiers: tier one assessed heterogeneity in subjects with data from the EPDS and tier two
consisted of cases with postpartum depression. There were 6,556 cases in tier one and 4,245 in
tier two. Three classes were established for both tiers with class 1 having the least severe
symptoms (mean EPDS score 10.5), class 2 (mean EPDS score 14.8), and class 3 (mean EPDS
score 20.1). It was determined that postpartum depression appears to have several clear
phenotypes. In addition, increased rates of history of anxiety and mood disorders were found in
the class 3 group, those with the most severe symptoms, supporting previous research on the
strength of previous history as a risk factor for PMADs (PACT Consortium, 2015). Corwin,
Kohen, Jarrett, and Stafford (2010) reviewed the genetic components of postpartum depression
and concluded that although genetic polymorphisms may be linked to an increased risk of
postpartum depression, the genes associated with PMADs would need to be identified, as well as
the interactions between these genes, in order to identify a genetic risk profile.
Biological models focus on the rise of reproductive and stress hormones in pregnancy
and the abrupt decrease at delivery, triggering depressive symptoms in women with a genetic or
biological vulnerability (Yim, Tanner, Guardino, Hahn-Holbrook, & Schetter, 2015). In a study
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of 16 healthy 22-45-year-old women with regular menstrual cycles who were at least one year
past any recent childbirth, Bloch et al. (2000) divided the women into two groups. One group
had a history of postpartum depression without a history of nonpuerperal depression. The
second group had no history of current or previous mental illness. In the baseline phase,
participants received injections of a gonadotropin-releasing hormone analog to create a
hypogonadal condition. In the addback phase, hormones were added back and in the withdrawal
phase, medications were replaced with placebo, which induced a dramatic drop in reproductive
hormone levels. Subjects received psychometric assessment during the study. Analysis of
variance with repeated measures indicated that there were significant differences in phases and
groups. Participants with a history of postpartum depression had a significant increase in
symptom severity during the withdrawal phase with a mean score 6.3+3.8 on the EPDS as
compared to 0.3+0.5 for the low risk group (p<.01), indicating a differential response to the
abrupt decrease in hormones in women participants with a history of postpartum depression.
This study established the existence of a hormone-sensitive phenotype for postpartum
depression.
Psychological models studying the etiology of PMADs focus on socioeconomic factors,
stressors, and interpersonal relationships. Factors such as age, education level, employment
status, income, and parity have been associated with increased risk for PMADs. A crosssectional screening study of 1,359 postpartum women using the EPDS was conducted to examine
the differences in depressive symptoms and associated factors. The highest depression rates
were found in the youngest age group (18-24 years): 16.4% for mild depression and 29.9% for
moderate to severe depression. Participants in the lowest income bracket had the highest
depression rates compared to other income groups: 18.9% for mild depression and 31% for
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moderate to severe depression. Lower education levels, higher parity, and unemployment were
positively correlated with depression rates. A multivariate analysis indicated income, age,
education, and parity were independently correlated with a score of 13 or higher on the EPDS,
indicating moderate-to-severe depression symptoms (Mayberry et al., 2007).
A key risk factor for perinatal depression and anxiety is a previous history of depression
or anxiety. In a prospective cohort study of pregnancy outcomes and maternal and child health,
1,662 women completed a questionnaire eliciting history of depression and EPDS scores during
pregnancy and 6 months postpartum. The greatest risk factor for antepartum depression was a
history of depression (OR=4.07, 95% CI: 3.76, 4.40). The greatest risk factor for postpartum
depression was depressive symptoms during pregnancy (OR= 6.78, 95% CI: 4.07, 11.31) or a
history of depression prior to pregnancy (Rich-Edwards et al., 2006). Similar findings were
found in a meta-analysis of 57 studies in which the greatest risk factor identified was a history of
depression (Langan & Goodbred, 2016).
Unintentional pregnancy has been identified as a risk factor for PMADs. In a prospective
cohort study, 2,128 women were screened for depressive symptoms using the EPDS during
pregnancy, and 1,278 of the participants completed the EPDS at 6 months postpartum.
Demographic information was collected via interview and survey. A cutoff score of 12 was used
to identify probable depression. A total of 9% of antepartum patients scored >12 on the EPDS
(n=155), and 8% (n=101) scored >12 in the postpartum period. This study modeled
sociodemographic predictors of depressive symptoms in the antepartum and postpartum periods.
Findings included a more than two-fold increase in association between unintended pregnancy
and risk for depressive symptoms during pregnancy (OR=2.31 95% CI: 1.29, 4.16). When the
researchers reran the model at 6 months postpartum with women who did not have a history of
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depression, a weaker association was identified (OR=1.89, 95% CI: .85, 4.20) indicating the
influence of a history of depression. Because there was an increased risk for depression in
participants with unintended pregnancy and no history, unintended pregnancy may be an
independent risk factor (Rich-Edwards et al., 2006). In a review of data from the National
Survey of Family Growth (NSFG), Finer and Zolna (2016) analyzed rates of unintended
pregnancy from 2008 to 2011. Of the 6.1 million pregnancies in the United States in 2011, 45%
(2.8 million) were unintended. An inverse relationship was identified among income and
educational level and unintended pregnancy. This study did not examine relationships between
unintended pregnancy and PMAD.
A cross-sectional study of 8,916 mothers was conducted to review the public health
impact of depression, prevalence, sociodemographic, and other factors. Utilizing data from the
National Epidemiological Survey of Alcohol and Related Conditions, findings indicated
depression was highly associated with socioeconomic factors, and depressed mothers faced more
challenges, for instance, unemployment, poverty, single parenting, and financial difficulties.
Young mothers, those with low education or income levels, unemployed, or divorced or
separated, had higher rates of depression. Models predicting depression indicated higher rates of
depression related to age 18-24 (OR=1.38, 95% CI: 1.02, 1.85), education less than high school
(OR=1.65, 95% CI: 1.16, 2.36), lowest quartile income <$20,000 (OR=1.53, 95% CI: 1.09,
2.15), unemployed (OR=3.27, 95% CI: 2.50, 4.28), and divorced or separated (OR=1.87, 95%
CI: 1.47, 2.39) (Ertel, Rich-Edwards, & Koenen, 2011).
Mothers of preterm and critically ill infants are at increased risk for depression and
anxiety. In a study that was a subset of a prospective, longitudinal study of 69 mothers and their
very low birth weight (VLBW) infants in an urban academic center in the United States,
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psychological distress and psychological history were recorded along with demographic
information and infant outcome variables. Questionnaires were administered at two time
intervals: T1–two to four weeks after delivery and T2–a mean interval of 14.8 days prior to
discharge. From T1 to T2, 65.5% of participants met criteria for at least one domain of distress
such as depressive symptoms, anxiety, or post-traumatic stress. Multiple regression analysis
indicated that being single and/or being in a relationship but not living together were associated
with higher depressive symptomatology at T1 (Greene et al., 2015).
The increased depression and anxiety risk was demonstrated in a cohort study in
Hamburg, Germany of 230 families, 111 with very low birthweight infants (VLBW) and 119
with term infants. The families were prospectively followed and were administered the EPDS,
Beck Depression Inventory (BDI) and structured clinical interview. With a reference of EPDS
>13, parents with VLBW infants had a 5.1 times higher risk for postpartum depression than term
infants (OR=5.1, 95% CI: 2.24, 11.80) (Helle et al., 2015). Similarly, a cohort of 73 mothers of
preterm infants was administered the EPDS and the State-Trait Anxiety Inventory (STAI); 20%
of mothers had depressive symptoms and 43% had moderate to severe anxiety (Rogers,
Kidokoro, Wallendorf, & Inder, 2013).
Racial and Ethnic Factors
Risk factors for PMADs have been well-studied, however the variation in prevalence by
race and ethnicity is unclear. Liu and Tronick (2013) reviewed birth certificate data and data
from the New York City (NYC) Pregnancy Risk Assessment Monitoring System (PRAMS), a
population-based survey of postpartum women. The goal of PRAMS was to monitor behavior
and experiences of mothers in the antepartum, intrapartum, and postpartum periods. A random
sampling of 180 mothers who had given birth in the previous two to four months answered
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several questions related to depression and questions about income, stressful events during
pregnancy, whether the pregnancy was planned, and level of social support. The outcome
variable for the study was a diagnosis of depression. Information about race, ethnicity, and
country of origin was obtained from birth certificate data. This study found Asian/Pacific
Islander women had the highest postpartum depression rates followed by Hispanics and African
Americans; however, after adjusting for sociodemographic factors, these differences were either
less pronounced or eliminated. A finding in this study was that African Americans and Hispanics
with lower socioeconomic status were less likely to be diagnosed than White and Asian
participants, indicating that further study is needed regarding the process of diagnosing women
in lower socioeconomic groups.
In a review of an ongoing longitudinal study of a diverse group of women receiving
prenatal care at a university-based hospital clinic in Washington state, 1,997 women completed
at least one questionnaire at a clinic visit related to depression and anxiety using the Patient
Health Questionnaire short form (PHQ-15) (Kroenke, Spitzer & Williams, 2002). The PHQ-15
measures 15 physical symptoms related to mental disorders, health behaviors, sociodemographic
factors, and psychosocial factors. The objective was to examine racial and ethnic differences in
the prevalence of prenatal depression in a community-based sample of pregnant women. In this
sample, 5.1% reported depression with the highest rates in Blacks and Asian/Pacific Islanders as
compared to non-Hispanic White women. Study findings included African American women
(AOR=2.93, 95% CI: 1.38, 6.18) and Asian/Pacific Islander women (AOR=2.14, 95% CI: 1.02,
4.52) had higher odds of antepartum depression after controlling for sociodemographic,
psychiatric, behavioral, and other factors (Gavin et al., 2011). Further study on racial and ethnic
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differences related to PMAD is needed to clarify factors associated with differences in
depression prevalence.
Adverse Outcomes
PMADs affect mothers, fathers, infants, children, and ultimately, society. Mothers with
PMADs may have depressed mood, anhedonia, appetite and weight changes, sleep disturbances,
agitation, fatigue, difficulty concentrating, and suicidal ideation (American Psychiatric
Association [APA], 2013). Women experiencing postpartum psychosis, a less common and
more severe mental illness, occurring in 1-2 cases for every 1,000 deliveries, have more severe
mood disturbances, fluctuating between mania and depression, and experience delusions and
hallucinations (Doucet et al., 2009). Suicide is one of the leading causes of death in the perinatal
period (Palladino, Singh, Campbell, Flynn, & Gold, 2011).
Fathers are at increased risk for depression in the perinatal period, which may be
explained in part by maternal depression. In a meta-analysis of 43 studies that documented
depression in fathers between the first trimester of their partner’s pregnancy and the first year
postpartum, 10% of fathers experienced prenatal and postpartum depression with the highest
rates at the three to six-month postpartum period. Paternal depression was positively correlated
with maternal depression (Paulson & Bazemore, 2010). Another aspect of paternal depression
may be related to stress. Parents of babies admitted to neonatal intensive care (NICU) faced
increased stress. In an observational, longitudinal design study, fathers of infants admitted to the
NICU with an expected length of at least three weeks completed questionnaires at four time
points: on admission through 2 weeks (T1), 3 weeks from admission (T2), at discharge (T3), and
2 months after discharge (T4). The Parental Stress Scale (PSS) (Berry & Jones, 1995) was used
to measure stress and the EPDS was used to measure depression symptoms. At the T1 time
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period, 11.8% of fathers had high stress levels as defined by PSS>43, which decreased to 7.6% at
discharge (T3) and increased to 12.6% at T4. A decrease in major symptoms of depression as
defined by EPDS >13 was noted from 16.3% at T1, which decreased to 2% at T4. Although
symptoms of depression decreased, depressive symptoms and high levels of stress persisted in
some fathers across all measured time points. This study utilized a convenience sample and did
not collect information about pre-existing stress or history of depression. (Cyr-Alves, Macken,
& Hyrkas, 2018).
There are many ways in which PMADs affect infants and children including negative
birth outcomes and parenting practices affecting their social and emotional development.
Anxiety during pregnancy has been associated with preterm birth, the leading cause of infant
mortality globally (World Health Organization, 2017). A multicenter prospective cohort study of
5,337 women who gave birth in Montreal, Canada over a period of five years was conducted to
study stressors and measures of psychological distress. Pregnancy-related anxiety was
independently associated with increased spontaneous preterm birth after controlling for medical
and obstetric risk (Kramer et al., 2009). The All our Babies (AOB) cohort study in Calgary,
Alberta, Canada included 3,388 pregnant women who completed questionnaires at 17-24 weeks
and 34-36 weeks of pregnancy. Anxiety was measured using the Speilberger State Anxiety
Scale (Spielberger, 2010) and depression was measured using the EPDS. Chronic stress was
measured once at 17-24 weeks of pregnancy using the Perceived Stress Scale (PSS) (Cohen,
Kamarck, & Mermelstein, 1983). Findings included that women with an increase in anxiety
during pregnancy had higher odds of preterm birth as compared to the women who had
decreased anxiety during pregnancy (OR=2.7, 95% CI 1.28, 5.69; p=.009). Women with
consistently low or high anxiety did not have significantly greater odds of preterm birth. A
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significant relationship was not found between increased depression scores during pregnancy and
preterm birth (Doktorchik et al., 2017).
Anxiety in pregnancy has also been linked to adverse infant development and
malnutrition. A prospective cohort study of 160 infants of depressed mothers and 160 infants of
mothers who were not depressed was conducted to examine the impact of maternal depression on
infant malnutrition and illness. Infants were weighed and measured at three different intervals in
the first year and mothers’ mental status was reassessed at the same intervals. The study found a
significant relative risk of the infants being underweight (RR=4.0; 95% CI: 2.1-7.7) at 6 months
of age and (RR= 2.6; 95% CI: 1.7-4.1) at 12 months of age when the mother was depressed. The
association between maternal depression and relative risk of underweight for infants was
significant after adjusting for confounders such as birth weight and socioeconomic status
(Rahman, Iqbal, Bunn, Lovel, & Harrington, 2004).
The negative birth outcomes associated with PMADs may be mitigated through
preventative programs. In a randomized control trial studying the preventive effects of a
parenthood program, a sample of 399 couples was enrolled in a study if they were expecting
their first baby, were cohabitating or married, and were at least 18 years old. The couples were
randomly assigned to an intervention or control group. The intervention group attended nine
classes on a number of skills including communication and conflict resolution. Stress and mental
health status were measured via the Center for Epidemiological Scale (CES-D) (Radloff, 1977),
and the State-Trait Anxiety Inventory (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983).
After delivery, data were collected on birth weight and birth date. One of the study findings was
the intervention appeared to buffer against the negative effects of financial stress, anxiety, and
depression on birth weight (Feinberg et al., 2016).
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Parenting practices can be adversely affected by PMADs. In a review of data from the
Early Childhood Longitudinal Study of 5,089 two-parent families, depressive symptoms were
assessed using a short form of the Center for Epidemiological Studies Depression Scale (CESD)
(Radloff, 1977). Interviews provided information on interactions among parents and infants.
Depression was identified in 14% of mothers and 10% of fathers and depressive symptoms were
negatively associated with positive interactions among parents and infants. When parents were
depressed, they spent less time reading or telling stories to their infants (Paulson et al., 2006).
Maternal depression can affect children’s social and emotional development. In a
longitudinal cohort study of 3,752 women in Oslo, Norway, study participants were given the
EPDS during pregnancy, at 8 weeks postpartum, and 2 years after delivery. Emotional
development in the children was assessed using the Ages and Stages Questionnaire: SocialEmotional (ASQ:SE) (Squires, Bricker, & Twombly, 2002) as well as parent questionnaires
about the children’s behavior. Depressive symptoms during pregnancy or during the postpartum
period were independently associated with social and emotional problems in children as
compared to the children of mothers who were not depressed. The Adjusted Odds Ratio for
children’s social and emotional problems 2 years after birth (adjusted for social support, current,
and perinatal depression), was 3.4; 95% CI 1.4-8.0, p=.01 during pregnancy, 3.8; 95% CI 1.78.6, p=.01 at 8 weeks postpartum, and 3.7; 95% CI 1.3-10.1, p=.01 at both occasions (Junge et
al., 2016).
Parental depression can have lasting effects on children. A prospective longitudinal
cohort study of 3,176 father and child pairs in the United Kingdom found that children of fathers
who were depressed during the postpartum period had an increased risk of depression at age 18
with a higher risk in female children after adjusting for paternal education and age .053; 95%
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CI .02-.09, p=.004. The authors state this was explained by the indirect associations of maternal
depression at 8 months postpartum (Gutierrez-Galve et al., 2018).
Factors Affecting Identification and Treatment
Screening
One of the factors contributing to the low rate of identification of women with PMADs is
a lack of consistent screening. Screening for depression at least once during the perinatal period
for depression and anxiety symptoms utilizing a standardized validated instrument is
recommended by the American College of Obstetricians and Gynecologists (ACOG). The
Committee Opinion Number 630 previously published in 2015 was updated in November 2018
as Committee Opinion Number 757 to add that a full assessment of a patient’s mood and
emotional well-being be conducted for each patient (ACOG, 2018).
The American Academy of Pediatrics (AAP) published a report in 2010 recommending
screening for perinatal depression in pediatric primary care at one, two, four, and six month wellbaby visits (Earls, 2010). Pediatricians are in a unique position to help identify PMADs since
mothers typically have regular contact with pediatric care providers in the first year of a baby’s
life. A 2013 survey of AAP members indicated that less than half of pediatricians were
screening mothers. A 2019 AAP policy statement reinforced the recommendation that screening
be included in well-child visits and recommended that pediatricians be provided with training
and continuing medical education programs regarding perinatal screening and referral (Earls et
al., 2019).
A literature review of articles published between 2003 and 2013 regarding physician
attitudes towards perinatal depression screening included 11 research studies in the United
States. The screening practices of pediatricians, obstetrician/gynecologists, and family
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practitioners were reviewed. Screening was perceived to be the role of 75%-90% of physicians;
however, 55% reported that they never, sometimes, often, or always completed screening.
Clinical judgment was the most common screening method; a screening tool was used by 7% of
pediatricians and 36% of obstetricians. (Evans, Phillippi, & Gee, 2015).
The feasibility of screening was demonstrated in a prospective cohort study in a
Midwestern urban pediatric outpatient clinic. New mothers were routinely screened for PMADs
at their 2-month and 4-month well-child visit using the EPDS, and a 6-month screening was
added. In addition to the EPDS, a survey was administered regarding the feasibility of adding a
6-month screening. At the 6-month point, 43 participants were screened; six had scores >10
indicating that they were at risk and of these six, two had not previously been identified. The
survey indicated more than half of the respondents agreed the additional screening would not be
a waste of time (Emerson, Matthews, & Struwe, 2018). This study not only included a small
sample, it also reviewed the feasibility of adding additional screening to a practice that already
had screening in place at well-child visits and may not be representative for pediatric practices
which have not yet implemented screening.
While screening in pediatric practices may be feasible, it may not occur consistently. In a
descriptive, cross-sectional design study, more than 80% of the 98 pediatric physicians and
advanced practice nurses surveyed agreed they were responsible for recognizing maternal
depression, yet only 7% used a screening questionnaire. Barriers to screening included
inadequate time, medical problems of the child being more pressing, mothers reluctant to accept
diagnosis, and incomplete knowledge of providers to diagnose or counsel (Connelly, Baker,
Hazen, & Muggenborg, 2007).
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The gap in screening for PMADs was demonstrated in a study conducted in a large, urban
teaching hospital in Boston, Massachusetts. A convenience sample of 491 women was screened
using the EPDS and the anxiety components of the Patient Health Questionnaire (PHQ) (Spitzer,
Kroenke & Williams, 1999) during the third trimester of pregnancy and again at 6 weeks after
delivery. The questionnaire mailed to participants at 6 weeks postpartum included additional
questions about stress and use of psychotropic medications. These data were correlated with
information from medical records regarding psychiatric symptoms, diagnoses, treatments, and
referrals to psychiatric services. Of the participants, 113 women (23%) screened positive for
anxiety or depressive symptoms prenatally but only 46 (41%) of these participants’ medical
records included documentation of symptoms or diagnoses. Of these 46 women, only 17 (37%)
had documentation of mental health treatment. In the postpartum portion of the study, 299
women (61%) completed the questionnaire and 51 (17%) screened positive for anxiety or
depressive symptoms. Of these 51 women, 15 (29.4%) had documentation of symptoms or
diagnoses in the medical record, and 13 (87%) had documentation of mental health treatment. By
comparing anxiety and depression symptoms in the antepartum and postpartum periods with
medical record documentation, this study identified a gap between self-reported symptoms and
identification of PMADs (Goodman & Tyler-Viola, 2010).
Patients may not be averse to being screened. In a mail survey of 168 women in the first
year postpartum, Walker, Murphey, and Xie (2016) reviewed discussions between patients and
providers on topics such as behavioral and psychological health and acceptability of mental
health screening. Just over 48% of participants indicated that behavior or psychosocial health
topics were not discussed in any health care visits during the year after giving birth. More than
94% indicated they would welcome or not mind completing a questionnaire about depression on
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a computer or tablet at a women’s health visit. The majority of participants (92%) indicated they
were comfortable answering similar questions during a pediatric health visit.
If screening is completed only once during the perinatal period or at a time when
symptoms are not present, patients at risk may be missed. The objective of a retrospective cohort
study in Camden, New Jersey was to determine if screening once using the EPDS is enough and
whether screening once within 96 hours after delivery is predictive of a later EPDS score done at
the outpatient postpartum visit. The majority of studies utilizing the EPDS have been conducted
in the outpatient setting. This study screened patients in the hospital using the EPDS and again
at 2 and 8 weeks postpartum as per usual practice. Further evaluation was conducted for EPDS
scores >10 or for suicidal ideation. Inpatient EPDS scores were compared with outpatient EPDS
scores for 256 participants and three groups were identified based on EPDS scores. The low risk
group had EPDS scores <10, borderline risk was 10-13, and high risk was >14. The final sample
size was 205 after cases were excluded such as when two EPDS scores were not available or if
they were completed outside the study interval. Delivery and outpatient records were reviewed.
The majority of participants (92%) fell in the low risk group, 5.4% were in the borderline group,
and 2.4% were in the high-risk group. In comparing EPDS scores between the three time periods
(inpatient, first outpatient, second outpatient), low risk participants had a 92.7% probability of
continuing to be low risk. Participants with worsening EPDS scores had a significant difference
in previous history of mental illness (p=.003) and fetal anomaly (p=.05) as compared to those
whose EPDS scores were unchanged or improved (Knights, Salvatore, Simpkins, Hunter &
Khandelwal, 2016). This study supports the need to screen women more than once during the
perinatal period, and screening during the hospital stay by nurses may be an effective way to
identify patients at risk so they can be referred to resources.

24
Stigma
A significant factor contributing to the low rate of identification of women with PMADs
is stigma. The Surgeon General’s 1999 report found in addition to stigma impacting a person’s
acknowledgement of a mental illness, stigma also affects seeking treatment and staying in
treatment (Office of the Surgeon General, 1999). Avoiding the label of mental illness is one
reason why people choose not to pursue treatment for mental health (Corrigan, 2004). Erving
Goffman (1963) in his seminal work described stigma as a discrediting attribute that makes a
person different from others, reducing the person in our minds to someone who is tainted and
discounted. Goffman’s conceptualization of stigma is that it effectively inhibits an individual
from being fully accepted by society.
Building on Goffman’s work, Corrigan (2004) described stigma as an experience of two
interdependent concepts: public stigma and self-stigma. Public stigma is the stigma directed by
the general population and self-stigma is the internalization of these thoughts, beliefs, behaviors,
attitudes, and stereotypes associated with a particular group. Moore et al. (2017) measured three
aspects of stigma in the development of the City Mental Illness Stigma Scale (City MISS)
(Moore et al., 2017): internal stigma, perceived external stigma, and disclosure stigma. A
convenience sample of 279 women, recruited via PMAD-related websites and social media,
completed the City MISS and Internalized Stigma of Mental Illness Scale (ISMI) (Boyd,
Otilingam, & Grajales, 2003). The internal stigma subscale was developed to describe the
association between internal stigma and a mother’s feelings of inadequacy. The external stigma
subscale measures the stigma a mother perceives others think about mothers with mental health
issues. The disclosure stigma subscale measures the expected discrimination if symptoms were
disclosed. Internal reliability for the City MISS total scale and subscales were as follows:
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Cronbach’s alphas of .84, .81, .86, and .85 respectively. The City MISS is the first instrument
designed to measure the stigma experienced by women with PMADs.
Disclosure is an aspect of stigma that may inhibit women from being identified and
treated. Dennis and Chung-Lee (2006) found in a qualitative, systematic review, a common
barrier to help-seeking was an inability to disclose symptoms further hindered by social
pressures and the label of mental illness. Disclosure stigma may be related to treatmentavoidance and in some cases pertains to a fear of having to discontinue breastfeeding. Mothers
may avoid treatment as a result of potential contraindication between breastfeeding and
psychotropic medications. A convenience sample of 509 pregnant women, in the last trimester
of pregnancy, completed a questionnaire regarding treatment modalities for depression, attitudes
toward depression treatment, and perceived barriers. Ninety-two percent responded they would
participate in therapy if they needed help. Only 35% stated they would take medication. Most
women reported they would not take psychotropic medication while pregnant (66%) or lactating
(64%). This study supports the concern mothers with PMADs face when wanting to continue to
breastfeed their infants (Goodman, 2009).
Continuing breastfeeding may be protective for depression and anxiety symptoms. In a
prospective cohort study conducted in Norway, researchers studied the relationship among
breastfeeding cessation, depression, and anxiety symptoms. The cohort of 42,225 participants
from the Norwegian Mother and Child Cohort Study was assessed at 17 weeks’ gestation, 30
weeks’ gestation, and 6 months postpartum. This study supported earlier findings that
breastfeeding is associated with reduced depression and anxiety symptoms. Women with
prenatal anxiety and depression were more likely to have increased anxiety and depression after
breastfeeding cessation (Ystrom, 2012).

26
Literature exists regarding the prevalence of PMADs and the impact on the family;
nonetheless, few quantitative studies were found reporting the relationship between PMADs and
stigma. In a descriptive study of 509 women in the last trimester of pregnancy, participants
completed the EPDS, a questionnaire on treatment preferences for depression or anxiety, and a
survey on barriers to obtaining professional help. The top perceived barrier to obtaining help for
depression or anxiety was time (64.7%), followed by stigma (42.5%) (Goodman, 2009). The
focus of this study was on treatment preferences and did not explore the relationships between
stigma and PMADs in depth.
Qualitative studies have identified several themes related to PMAD and stigma. Stigma
was a theme in the grounded theory focus group study conducted by Byatt et al. (2013)
examining barriers to identifying postpartum depression in pediatric settings. The theme was
ambivalence about screening due to concerns about stigma and losing parental rights. Abrams
and Curran (2011) interviewed low income mothers with infants 12 months or younger in the
Women, Infant, and Children (WIC) federal nutrition program in two cities. One of the central
constructs identified was depression creates a sense of failure and mothers attached a “bad
mother” stigma to themselves. Not only is there the external stigma of being viewed as a bad
mother, there is also the internalization of that stigma and a sense of failure and guilt. Women in
this population face the double stigma of depression and poverty.
Social Support
While stigma may inhibit women from seeking treatment, social support may be a
positive mitigating factor. In a prospective cohort study, 222 postpartum women completed the
EPDS, the Maternity Social Support Scale (MSSS) (Webster et al., 2000), and the World Health
Organization Quality of Life assessment (World Health Organization, 1995) questionnaire 6
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weeks after delivery. A cutoff >10 for the EPDS indicates probable depressive symptoms and in
this study, 47 (21.8%) scored >10 on the EPDS. Women with a score >10 were contacted by
telephone for further follow up. The highest possible score for the MSSS is 30 with higher
scores indicative of higher levels of social support. Women with scores 0-24 on the MSSS had a
mean score of 9.41 on the EPDS; in contrast, women with MSSS scores >24 had a mean score of
6.74 on the EPDS indicating a statistically significant (p=.0007) inverse relationship between
social support and depressive symptoms (Webster et al., 2011).
A descriptive, correlational study was conducted to examine the relationships among
social support, maternal parental self-efficacy, and depression in first-time mothers in a
maternity unit in the Republic of Ireland. Four hundred and ten mothers completed
questionnaires at 6 weeks postpartum including the EPDS and the Perceived Maternal Parental
Self-Efficacy Scale (Barnes & Adamson-Macedo, 2007), an instrument measuring functional
social support and structural social support. Family and friends were identified as the main
source of social support (mean 4.94, SD 1.8). The study identified a statistically significant
correlation between social support and maternal prenatal self-efficacy (r=0.21, p<.001) and
statistically significant negative correlations between social support and EPDS scores (p<.001).
This study supports the association among informal social support (family and friends) and
parental self-efficacy as well as the inverse relationship between social support and postpartum
depression (Leahy-Warren et al., 2011).
Summary
The etiology of PMADs is multifactorial and any approach to studying PMAD
must incorporate quantification of several risk factors to include history of depression, young
age, low education level and income, high parity, and low social support (Langan & Goodbred,
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2016). There are adverse outcomes affecting the entire family as a result of PMADs including
sleep disturbances and suicidal ideation in mothers, pre-term birth and adverse development in
infants, and depression in partners (Miller, 2002; Wisner, Parry, & Piontek, 2002). Screening and
stigma are factors affecting the identification and treatment of women with PMAD; in contrast,
social support can be a positive mitigating factor (Byatt et al., 2013; Goodman & Tyler-Viola,
2010; Webster et al., 2011). There is a gap in the literature regarding relationships among
PMADs, stigma, and social support in postpartum women.
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Chapter 3
Methodology
The purpose of this study was to examine the relationships among select patient
characteristics, self-report of depressive symptoms, social support, and stigma of mental
illness in inpatient postpartum women. This chapter provides the research methodology
including study aims, research design, sample and sampling, instruments, data collection
procedures, data analysis, and protection of human subjects.
The research questions for this study include:
Research Question 1: Is there a relationship between stigma and PMAD
symptomatology?
Research Question 2: Are there differences in the type of stigma (external,
internal, and disclosure) and PMAD symptomatology, social support, and demographic
factors such as age, race/ethnicity, and pregnancy intent?
Research Question 3: What percentage of participants with PMAD
symptomatology seek treatment after discharge?
Research Question 4: What is the level of agreement between the current
admission screen and the interview screen using the EPDS and GAD-7?
The research questions were addressed through the following aims:
Aim 1. Characterize a cohort of inpatient postpartum women participating in motherinfant dyad care.
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support,
and select demographics within a sample of inpatient postpartum women.
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Aim 3. Assess treatment-seeking in women with PMAD symptomatology after discharge
from the hospital.
Study Design
A descriptive cross-sectional correlational design was used in this study. The
rationale for this study design is, although much is known about the prevalence of and
risk factors for PMADs, the literature lacks consistency of findings related to the
relationships among PMADs, stigma, and social support in postpartum women. This
study will provide an opportunity to better understand the relationship among these
variables in a diverse sample of postpartum women.
Sample and Sampling Plan
A purposive sample of inpatient postpartum mothers who gave birth between July
2018 and August 2018 at a 208-bed free-standing women’s community hospital located
in a large southern California metropolitan area was recruited and enrolled. The patient
population in this hospital is diverse with approximately 44% non-Hispanic White, 19%
Hispanic, 10% Asian, 5% African American, 0.2% Native American, and approximately
21% other. Inclusion criteria: minimum of 24 hours post-delivery to ensure participants
were adequately recovered from delivery with infants in dyad care and English or
Spanish speaking. Languages chosen were based on the availability of bilingual
Research Assistants (RA). Exclusion criteria: mothers whose babies were in Neonatal
Intensive Care or at the local children’s hospital. This exclusion was established because
of the increased risk for depression and anxiety in mothers with preterm and very low
birth weight infants (Helle et al., 2015; Rogers et al., 2013).
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Power Analysis. The greater the variability in the population, the higher the risk
a larger sample is needed to capture the full variation in the sample (Polit, 2010; Polit &
Beck, 2012). This study included nine independent variables to be tested within a
bivariate logistic regression model. There is no recognized power calculation for logistic
regression but a general rule to ensure adequate cell size in the contingency tables is a
minimum of 20 cases for each independent variable, or 180 mothers. This was
considered to be sufficient to detect a moderate standardized Effect Size (d = 0.32) using
a two-tailed significance test with a power of .80 and a significance level of .05 (Cohen,
1988; Polit & Beck, 2012).
Procedures
Recruitment and Enrollment Strategies
Fliers recruiting patients for the study were distributed to postpartum nursing staff
at shift huddles to introduce the study (Appendix A). A brief explanation of the study
was provided to nurses so they could answer basic questions about the study. Each day
of data collection, the Principal Investigator (PI) reviewed the list of potential patients
and screened them for inclusion. The PI or bilingual RA then invited them to participate,
obtained informed consent (Appendix B), and provided subjects with the survey study
packet including resources for follow-up and instruments for self-scoring after discharge.
The survey packet was comprised of four de-identified standardized measures and
a demographic survey including age, race/ethnicity, marital status, parity, pregnancy
intent, language, type of delivery, and history of mental illness. It was estimated the
study instruments would take participants no more than 15 minutes to complete. After
obtaining informed consent and reviewing the survey packet, the PI or RA returned at a
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pre-arranged time to collect the packets. If a participant responded positively to question
#10 on the EPDS, “The thought of harming myself has occurred to me,” the participant
was visited by a social worker to determine if further follow-up was needed. Participants
were given the option of providing their phone number for additional resources after
discharge and those who scored 10 or higher on the EPDS or GAD-7 were contacted by
the PI approximately one month after discharge to identify (or assess) if they obtained
further evaluation and treatment. In acknowledgment of their time, a $10 gift card was
provided to participants and a copy summary of the study results was made available to
participants if they asked to receive one.
Ethical Considerations
The proposed investigation was reviewed and the Institutional Review Board
(IRB) of the participating hospital and the University of San Diego provided study
oversight. Informed consent was obtained through an introductory letter attached to the
study instruments. Participation in the study was voluntary. Precautions were taken to
protect patient privacy in accordance with the Health Insurance Portability and
Accountability Act (HIPPA). Subject-level data were recorded using only a study ID
number and no personal identifying information. All study data were accessible only by
the investigator. During the investigation period, all printed materials were kept in a
secure, locked office, accessible only by the PI.
Variables and Operational Definitions
Variables included demographic variables, study variables, and an outcome
variable.
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Demographic Variables
Data were collected on potential covariates including age, race/ethnicity, primary
language, marital status, parity, whether the pregnancy was planned or unplanned, type of
delivery, and mental health history. Although the correlations between race, ethnicity
and PMADs may be more a result of sociodemographic factors, race/ethnicity and
primary language were included in the demographic survey. Young age, lower education
levels, single parenthood, high parity, unintended pregnancy, and mental health history
are associated with an increased risk of PMADs; therefore, these factors were also
included in the demographic survey. Age was measured in years. Race/ethnicity was
measured by the following classifications: White, Black, Hispanic, Asian/Pacific
Islander, and Multi-ethnic. Primary language was measured as English, Spanish, or other
(write in). Marital status was measured as married, single living with the father of the
baby, and single not living with the father of the baby. Parity was measured by the
number of previous live births. Intention for pregnancy was measured as yes for planned
pregnancy, no for unplanned pregnancy. Although evidence regarding a relationship
between type of delivery and risk for PMADs was not identified in the literature, type of
delivery was included and was measured as vaginal, planned Cesarean section, or
unplanned Cesarean section. Mental health history was measured as history of
depression, anxiety, both depression and anxiety, other mental health diagnosis, or no
history/no answer.
Depression
Depressive symptomology was measured by the EPDS, a 10-question
screening instrument, asking the participant to rate how she had been feeling the previous
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seven days. Responses were scored on a scale from 0-3. The scores were totaled and
ranged from 0 to 30 with a higher score indicating greater depressive symptomatology.
A score identification of possible depression and anxiety was based on a pre-determined
cut-off score. Cox and colleagues, who developed the EPDS, found a cut score of 12 or
greater identified more than 80% of mothers with a major depressive disorder (Cox et al.,
1987). A systematic review of validation studies identified the most commonly used cutoff scores of 9-10 for possible depression, 12-13 and higher for probable depression
(Gibson, Mc Kenzie-McHarg, Shakespeare, Price, & Gray, 2009).
Reliability and validity studies by the developers of the EPDS identified
sensitivity 86%, specificity 78%, and positive predictive value 73%. The alpha reliability
was .87 (Cox et al., 1987). The EPDS is publicly available and has been extensively
validated across multiple community, culturally, and ethnically diverse populations and
may be administered in Spanish or English (Alvardo-Esquivel, Sifuentes-Alvarez, SalasMartinez, & Martinez-Garcia, 2006). The EPDS has been translated into many
languages. In this sample the Cronbach alpha was α =.81.
Anxiety
Anxiety symptomatology was measured using the GAD-7 (Spitzer et al., 2006), a
7-item screen, asking the participant to rate emotions over the previous two weeks on a 4point Likert scale. Responses are scored on a scale of 0 to 3 and total possible scores
ranged from 0-21 with higher scores indicating greater anxiety symptomatology.
Reliability for the GAD-7 was established by the instrument developers with Cronbach’s
alpha=.92 and test-retest reliability was 0.83. Convergent validity with the Beck Anxiety
Inventory was demonstrated (r=.72). Level of Anxiety Severity GAD-7 Scale scores were
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established with scores of 0-4 associated with minimal anxiety, 5-9 mild anxiety, 10-14
moderate anxiety, and 15-21 severe anxiety (Spitzer et al., 2006). A random sample of
965 patients in family practice and internal medicine clinics were given the GAD-7
followed by structured interviews with a clinical psychologist or senior psychiatric social
worker. The study found 89% of patients who scored >10 were diagnosed with
Generalized Anxiety Disorder (GAD) and 82% of participants who scored <10 did not
have GAD (Spitzer et al., 2006). The GAD-7 has been translated into multiple languages
and is publicly available. In this sample the Cronbach alpha was α= .91.
Stigma
Stigma of mental illness was measured by the City MISS, an instrument designed
to measure the stigma specific to PMAD. This is a new instrument first described and
published by Moore and colleagues in 2017. Scale items were derived directly from
women’s experiences of stigma in the literature. The instrument is a 15-item, 4-point
Likert scale through which participants rate questions from strongly disagree to strongly
agree. Scores range from 1, indicating lower stigmatizing beliefs, to 15, indicating higher
stigmatizing beliefs. The City MISS instrument is composed of three subscales
measuring three aspects of stigma: internal stigma, perceived external stigma, and
disclosure stigma. Internal stigma is the internalization of beliefs that a mother with
mental illness will be thought of as a bad mother. There are five items in the internal
stigma subscale; for example, “I can’t cope as well as I’d like with my baby.” Perceived
external stigma is what the participant believes others think about a mother’s ability to
fulfill their role as a mother when they have psychological issues. The subscale contains
six items; for example, “People think mothers with psychological problems are
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abnormal.” Disclosure stigma is the stigma related to expected discrimination if the
participant discloses mental illness to others. There are four items in the disclosure
subscale; for example, “I worry that if I told a health care provider about my
psychological problems, my baby would be taken away.” Cutoff scores have not yet been
designated for this instrument or the subscales to delineate low, moderate, or high levels
of perinatal mental illness stigma. Psychometrics indicate the internal consistencies for
the subscales are adequate: α = 0.84 for total scale, α = 0.86 for perceived external
stigma, α = 0.81 for internal stigma, and α = 0.85 for disclosure stigma (Moore et al.,
2017). The City MISS is not yet available in languages other than English and was
utilized by permission from the developers. In this sample the Cronbach alpha was α=.88.
Social Support
Social support was measured using the Multidimensional Scale of Perceived
Social Support (MSPSS). Zimet and colleagues (1988) first published this 12-item, 7point Likert scale instrument in 1988. It is designed to measure perceptions of support
from family, friends, and a significant other. According to the instrument developers, a
mean total score ranging from 1-2.9 indicates low support, 3-5 indicates moderate
support, and 5.1-7 indicates high support (Zimet et al., 1988). The instrument has three
subscales corresponding with the three areas of support. Cronbach’s alpha scores are as
follows: 0.88 for the total scale, 0.91 for the significant other subscale, 0.87 for the family
subscale, and 0.85 for the friends subscale. The MSPSS has been translated into many
languages and is publicly available. In this sample the Cronbach alpha was α= .94.
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Treatment Seeking Definition
Positive treatment-seeking after discharge was defined by this researcher as
having scheduled or attended mental health treatment including postpartum depression or
anxiety support group or seeing a mental health professional such as a psychiatrist,
psychologist, or therapist.
Admission Screening Variables
A report generated from admission screening questions was used to evaluate the
level of agreement between the current admission screen and interview screen using the
EPDS and GAD-7. Admission screening questions were as follows: 1) Do you have a
history of depression, anxiety, or another mental health diagnosis? 2) During your
pregnancy, have you felt depressed or anxious to a degree that seemed unusual? 3) In the
recent past, have you had any thoughts of harming yourself or others?

Table 1.
Variables and operational definitions
Variables

Operational Definition

Age (categorical)

Age in years, 18 or older

Race/ethnicity (categorical)

Self-identifies as White, Black, Hispanic,
Asian/Pacific Islander, Multi-ethnic

Marital status (categorical)

Married, Cohabitating, Unpartnered

Parity (categorical)

Primapara or multipara

Primary language (categorical)

Self-identifies as English, Spanish, Other

Planned or unplanned pregnancy (categorical)

Pregnancy was planned, desired versus pregnancy
was not planned, was unexpected
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EPDS

Depressive symptoms 0-30 possible
0-8 low probability of depression/anxiety

(categorical for Group A <10, Group B>10)

9-10 moderate/possible depression/anxiety
>12 high/probable depression/anxiety

GAD-7

Anxiety symptoms 0-21 possible

(categorical for Group A <10, Group B>10)

0-4 minimal anxiety
5-9 mild anxiety
10-14 moderate anxiety
15-21 severe anxiety

MSPSS score (continuous)

7-point Likert scale=1 (very strongly disagree) to
7 (very strongly agree)

MISS score (continuous)

4-point Likert scale = 1 (strongly disagree) to 4
(strongly agree)

Treatment seeking

Yes – scheduled, planned, or ongoing support
group, visit with a mental health professional
No- no follow up planned

Data Analysis Plan
Descriptive and inferential statistics were used in this study. All study variables
were examined for normality, missing values, and outliers. Summary statistics were
calculated including frequencies for categorical variables and means with standard
deviations (SD) for continuous variables. Bivariate associations were examined with chisquared analysis for categorical variables and correlations for continuous variables. A
correlation matrix was constructed to identify the potential for multicollinearity.
Variables significant at p< .05 in the bivariate analysis were considered for entry into a
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logistic regression model to identify factors that increase the likelihood of treatmentseeking for participants identified as being at high probability of depression or anxiety.
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Chapter IV
Results
The purpose of this study was to examine the relationships among PMAD
symptomatology, select demographics, stigma of mental illness, and social support
among a sample of postpartum women on a mother-infant dyad care unit. The results
presented in this chapter include a descriptive profile of the sample followed by results
related to the specific aims and research questions.
Aim 1. Characterize a cohort of inpatient postpartum women participating in motherinfant dyad care.
Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support,
and select demographics among a cohort of inpatient postpartum women.
Aim 3. Assess treatment seeking in women with PMAD symptomatology after discharge
from the hospital.
Participants
Aim 1. Characterize a cohort of inpatient postpartum women participating in
mother-infant dyad care.
A convenience sample of 105 English and Spanish speaking women was recruited
and enrolled from a Southern California woman’s specialty hospital postpartum unit,
between July 2018 and August 2018. Mothers had given birth 24 or more hours prior to
recruitment. Mothers were not included if they were separated from their infants. Study
instruments were administered in English and Spanish based on the individual’s stated
primary language in the electronic medical record and participant preference. A
bilingual, bicultural RA consented Spanish-speaking participants.
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The demographic characteristics of the sample are summarized in Table 2.
Comparisons were made between those scoring <10 on the EPDS or GAD-7, referred to
as Group A, and those scoring >10 on the EPDS or GAD-7, referred to as Group B. The
mean age (and SD) for the combined group was 30.8+5.02 (range 18-46). Mean years of
education were 15.2+3.2 (range 0-23), and mean previous births were 1+1.06 (range 0-4).
Groups A and B were similar in terms of ethnicity and primary language with 46% of
participants in Group A and 43.8% in Group B self-identified as Hispanic; English was
the primary language (73.6% in Group A, 75% in Group B). None of these differences
were statistically significant. Pregnancy was planned for 72.8% of the groups combined
with slightly higher rates (74.7%) in Group A as compared to 62.5% in Group B. Less
than half (46.5%) of both groups combined had planned or unplanned Cesarean sections
with higher rates in Group B (68.8%) as compared to Group A (42.5%). A higher
percentage of participants in Group A were married (73.6%) compared to Group B
(50%); 4.6% of Group A was single and not living with the father of the baby compared
to 25% of Group B (p=.01). Although there were significant differences between groups
for marital status, there were no significant differences for language, ethnicity, planned
pregnancy, or type of delivery. Regarding prior history of depression and anxiety, 36% of
participants reported some mental health history (n=33); however, because the
demographic survey did not include an option for no history, it is not possible to
determine the number of participants with no history as compared to those who did not
answer the question. The sample size for Group B was small (n=16), limiting sufficient
power, thus a logistic regression was not conducted.
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Table 2
Demographics
Mean
Group A
(+ SD)

Mean
Group B
(+ SD)

Range

Total Mean
(+SD)

FStatistic

P-value

Age

30.8+5.1

30.4+4.8

18-46

30.8+ 5.02

0.05

0.82

Years Education

15.4+2.9

14.4+4.7

0-23

15.2+3.2

1.51

0.22

Previous births

1.02+1.0

.88+1.2

0-4

1+1.06

0.26

0.61

Chisquared

P-value

0.26

1.00

3.2

0.48

6.95

0.01

1.38

0.35

4.42

0.10

Characteristic

Language
English

64 (73.6%)

12 (75%)

76 (70%)

Spanish

18(20.7%)

3(18.8%)

21(19.1%)

5(5.7%)

1(6.3%)

6(6.4%)

Other
Race/Ethnicity
Hispanic

40 (46%)

7 (43.8%)

47 (43.6%)

Black

3 (3.4%)

1 (6.3%)

4 (3.6%)

White

28 (32.2%)

6 (37.5%)

34 (30.9%)

Asian

10 (11.5%)

0(0%)

10 (10%)

6 (6.9%)

2(12.5%)

8(7.3%)

Multi-ethnic
Marital Status
Married

64 (73.6%)

8 (50%)

72 (69.9%)

Single, living with father
of the baby

19 (21.8%)

4 (25%)

23 (22.3%)

4 (4.6%)

4 (25%)

8 (7.71%)

Single, not living with
father of the baby
Pregnancy
Planned

65 (74.7%)

10 (62.5%)

75 (72.8%)

No planned

20 (23%)

6 (37.5%)

26 (25.2%)

Missing

2 (2.3%)

0

2(1.9%)

Type of delivery
Vaginal

50 (57.5%)

5 (31.3%)

55 (53.3%)

Planned C section

21 (24.1%)

5 (31.3%)

26 (25.2%)
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Unplanned C section

16 (18.4%)

6 (37.5%)

22 (21.3%)

Depression

3

0

3

Anxiety

11

4

15

Both depression and
anxiety

6

5

11

Other (i.e. bipolar)

3

1

4

53

6

59

Mental health history

No answer

Aim 2. Examine the relationships among stigma, PMAD symptomatology, social support,
and select demographics among a sample of inpatient postpartum women.
As described in Table 3, the mean EPDS score for the combined group in this
study was 4.7 +3.9, and the mean GAD-7 score was 3.9+4.2. The mean total score on the
City MISS was 1.5+.4, and the scores on the three subscales were as follows: internal
stigma (IS) 1.1+.2, external stigma (ES) 1.9+.7, and disclosure stigma (DS) 1.4+.7. The
mean MSPSS score was 6.4+.9 indicating overall high support. Mean scores for the
subscales were 6.6+.9 for the significant other subscale, 6.3+1.1 for the family subscale,
and 6.2+1.3 for the friends subscale.
The total sample consisted of 105 participants; missing values resulted in an
analysis sample of 103. Participants were separated into two groups: 87 (85%) scored
<10 on the EPDS or GAD-7 Group A; 16 (15%) scored 10 or higher on either the EPDS
or GAD-7 Group B. Significant differences between groups were noted for all study
instruments’ summary scores and subscales: EPDS, GAD-7, City MISS, City Internal
subscale, City External subscale, City Disclosure subscale, MSPSS, MSPSS Significant
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Other subscale, MSPSS Family subscale, MSPSS Friends subscale. The EPDS and
GAD-7 scores were significantly higher in Group B than Group A indicating higher
depression and anxiety symptomatology (p<.001). The overall City MISS score was
significantly higher in Group B than Group A (p=.002) indicating higher overall stigma
in the group with higher depression and anxiety symptomatology. Scores on all three
City MISS subscales were significantly higher for Group B than Group A indicating
higher levels of internal stigma (p<.001), external stigma (p=.03), and disclosure stigma
(p=.02). Overall MSPSS score was significantly lower in Group B indicating lower
overall social support in the group with higher depression and anxiety symptomatology
(p<.001). The scores on all three MSPSS subscales were significantly lower in Group B:
significant other subscale (p=.003), family subscale (p=.03), and friends subscale (p=.02)
indicating lower levels of social support from all three categories in the group with higher
depression and anxiety symptomatology.

Table 3
Means and Standard Deviations

Characteristic

Total
group
mean
(SD)

Range

Mean (SD)
Group A

Mean (SD)
Group B

F statistic

P-value

EPDS

4.7+3.9

0-21

3.57+2.4

11+4.6

91.2

<.001

GAD-7

3.9+4.2

0-21

2.7+2.4

10.5+5.7

83.5

<.001

City MISS

1.5+.4

1-15

1.5+.4

1.84+.4

10.2

.002

City MISS IS
subscale

1.1+.2

1-2

1.1+.1

1.3+.3

21.1

<.001

City MISS ES
subscale

1.9+.7

1-4

1.86+.7

2.3+.7

5.0

.03
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Disclosure stigma
(DS)

1.4+.7

1-3

1.39+.6

1.8+.7

5.9

.02

MSPSS

6.4+.9

1-7

6.54+.89

5.64+.9

13.5

<.001

MSPSS Significant
Other subscale

6.6+.9

1-7

6.74+.87

6.04+.8

8.9

.003

MSPSS Family
subscale

6.3+1.1

1-7

6.49+1.03

5.6+1.2

9.4

.003

MSPSS Friends
subscale

6.2+1.3

1-7

6.38+1.14

5.3+1.8

10.3

.002

Correlations among demographic variables are presented in Table 4. Significant
positive correlations were found between years of education and age (r= .28, p=.01),
previous births (r=.27, p=.01), and total MSPSS score (r=.32, p=.01), respectively.
Significant positive correlations for study variables are presented in Table 5 and were as
follows: EPDS and IS (r=.55, p=.01), ES (r=.34, p=.01), and DS (r=.23, p=.01) indicating
a higher level of all three dimensions of stigma with higher depression and anxiety
symptomatology. Significant correlations were found between EPDS and GAD-7 (r=.67,
p=.01) supporting the close relationship between depression and anxiety found in the
literature. Significant correlations were found between EPDS and total MISS score
(r=.40, p=.01), indicating a higher level of perinatal mental illness stigma with higher
depressive symptomatology. Significant correlations between EPDS and age, level of
education, and previous births were not found in this study. Similarly, relationships
between EPDS and ethnicity, language, marital status, planned pregnancy, and type of
delivery were not significant.
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Table 4
Correlations for Demographic Variables
Variables

Age

Age
Yrs of ed

.28**

Prev
births

-.004

Ed

Prev
births

EPDS

GAD

City
MISS

Internal
stigma

Ext
stigma

Discls.
stigma

MSPSS

.28**

-.004

.02

-.04

.06

.13

.06

.01

-.02

-.27**

-.06

.04

-.05

.11

-.06

-.06

.32**

-.11

-.034

-.06

-.15

.03

-.16

.06

-.27**

**=correlation is significant at the 0.01 level (two-tailed)
Table 5
Correlations for Study Variables
Variables

Age

Ed

Prev
births

EPDS

GAD

City
MISS

Int.
stigma

Ext
stigm
a

Discls
stigm
a

MSPSS

Total
EPDS

.02

-.06

-.11

.67**

.40**

.55**

.34**

.23*

-.28**

Total
GAD-7

-.04

.04

-.034

.67**

.42**

.40**

.38**

.23*

-.27**

Total City
MISS

.06

-.05

-.06

.40**

.42**

.44**

.92**

.76**

-.18

Internal
stigma
subscale

.13

.11

-.15

.55**

.40**

.44**

.29**

.26**

-.21*

External
stigma
subscale

.06

-.06

.03

.34**

.38**

.92**

.29*

.47**

-.08

Disclosure
subscale

.005

-.06

-.16

.23*

.23*

.76**

.26**

.47**

Total
MSPSS

-.02

.32**

.06

-.28**

-.27**

-.18

-.21*

-.08

**=correlation is significant at the 0.01 level (two-tailed)

-.24*
-.24*
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Aim 3. Assess treatment seeking in women with PMAD symptomatology after discharge
from the hospital.
A cut point of 10 was chosen for both instruments to indicate possible depression
or anxiety. A score of 10 or greater is an indication of possible depression, and a positive
response to Question 10 on the EPDS is indicative of possible suicidal thoughts (Cox et
al., 1987). A cut point of 10 on the GAD-7 is used to represent a moderate level of
anxiety (Spitzer et al., 2006). Of the 16 participants who scored >10 on the EPDS or
GAD-7, four had a positive response by answering “hardly ever” to Question 10 on the
EPDS. All denied current thoughts of self-harm or suicidal ideation when visited by a
social worker. Of the 12 who scored 10 or higher on the EPDS, three also scored 10 or
higher on the GAD-7 indicating possible coexistence of depression and anxiety. Four
participants scored 10 or higher on the GAD-7 but did not have a score >10 on the EPDS,
possibly indicating anxiety without depression.
Treatment seeking information is listed in Table 6. Providing a phone number
was voluntary and 6 of the 16 with scores >10 on either instrument chose not to provide a
phone number. Ten participants provided phone numbers and follow-up information was
obtained for six. Four did not answer the telephone after three or more attempts or had a
non-working phone number. Of the six who were reached by telephone, four (66%)
responded negatively to treatment-seeking. One with a score of 16 on the GAD-7
requested information about the hospital’s free PMADs support group. Two stated they
were doing well, did not report depressive symptoms, and were not seeking treatment.
These two participants had lower scores on the EPDS and low scores on the GAD-7, 11
and 12 respectively. One stated she had a previous history of PMAD and expressed
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interested in treatment; however, she did not return phone calls made by the social
worker for referrals. Two participants (33%) responded positively to treatment-seeking;
they were either in treatment or had visits with health professionals scheduled. The
sample size for treatment-seeking follow-up was very small and it was not possible to
contact all 16 study participants with PMAD; 33% were seeking treatment, and 66% had
not sought treatment at the time of the phone call.

Table 6
Treatment-Seeking Follow-Up
ID

EPDS

GAD-7

City
MISS

MSPSS

Reached
by phone?

Sought Tx
Y/N

6

7

16

2.66

7

12

5

11

18

30

Comments

4.75

Y

N

1.05

5.83

N

21

2.06

4.58

Y

5

13

1.73

5.66

N

34

11

6

1.6

6.66

N

38

11

7

Missing

5.33

Y

44

13

4

1.6

5.41

N

50

21

21

2.0

7.0

N

51

10

8

1.86

4.5

N

53

10

9

1.66

5.83

N

55

11

7

2.2

5.33

Y

Y

Appt
scheduled

63

15

14

2.2

5.33

Y

N

Phone contact,
referred to
Social Worker

73

8

14

1.73

6.75

N

85

12

5

2.2

6.5

Y

Interested in
support group

Y

N

No symptoms
Seen by Social
Worker in
hospital

No answer x3
N

No symptoms
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15S

10

4

1.73

4.08

N

No answer x3

18S

2

14

1.4

6.58

N

Number not
reachable

An additional finding was related to comparisons between a report with screening
results pulled from the electronic medical record during the study period and screening
from study instruments. Admission screening questions included the following:
1) Are you worried about taking care of yourself and/or your baby when you are
discharged home and would you like to discuss this with someone?
2) Do you have any history of depression, anxiety, or another mental health diagnosis?
3) During your pregnancy, have your felt depressed or anxious to a degree that seemed
unusual?
4) In the recent past, have you had any thoughts of harming yourself or others?
When the case data were examined for the period of this study (July 27, 2018 to
August 30, 2018), the results indicated 16% reported a history of depression, anxiety, or
other mental health diagnosis. Regarding depressive symptomatology during pregnancy,
5% of the cases reported feeling depressed or anxious to a degree that seemed unusual
during the pregnancy. Thoughts of self-harm were expressed by 0.8% of the cases. In
this study, participant data was not matched with the patients included in this report;
however, it is noteworthy that admission screening resulted in lower positive responses to
depression and anxiety screening. More than one third (36%) of study participants
reported a history of depression, anxiety, or other mental health diagnosis and 15% of
participants scored 10 or higher on the EPDS or GAD-7 indicating depression or anxiety
symptomatology. Although participants denied current thoughts of self-harm when
visited by a social worker, 3.8% of study participants indicated they had a history of
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thoughts of self-harm. These findings, although exploratory, support the need to utilize
standardized screening instruments.
Summary
In comparing Group A (those scoring <10 on the EPDS or GAD-7) and Group B
(those scoring >10), there were no significant differences in age, years of education,
previous births, language, ethnicity, planned pregnancy, or type of delivery. Because the
demographic survey did not include an option to indicate that they did not have a history
of depression, anxiety, or other mental health diagnosis, a comparison cannot be made
regarding mental health history. Significant differences were noted between groups
regarding marital status with more participants in Group A being married while Group B
participants were more likely to be single. Significant positive correlations were found
among groups for all study instruments and subscales: EPDS, GAD-7, City MISS, City
Internal subscale, City External subscale, City Disclosure subscale, MSPSS, MSPSS
Significant Other subscale, MSPSS Family subscale, and MSPSS Friends subscale. In
the post-discharge follow-up with patients with high depression and anxiety
symptomatology, six were reached by telephone approximately one month after
discharge and 33% sought mental health treatment while 66% had not sought mental
health treatment. The current hospital admission screening identified less positive screens
for history of depression, anxiety, and other mental health history, as well as less positive
screens for thoughts of self-harm as compared to the study instruments, supporting the
need for standardized screening instruments.
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Chapter V
Discussion of Findings
The purpose of this study was to examine the relationships among demographic
factors, stigma of mental illness, levels of social support, PMAD symptomatology, and
treatment-seeking in a sample of postpartum women in a women’s community hospital.
Additionally, a comparison was made between the hospital’s existing admission
depression and anxiety screening during the study time period and results from study
instruments. Goffman’s (1963) and Corrigan’s (2004) concepts of stigma provided
underpinnings for this research. The work of Zimet and colleagues (1988) regarding the
role of social support in potentially mitigating the effects of stigma provided an
additional framework for this study. In this chapter, a discussion of the findings and
implications for nursing practice, education, research, and policy are presented.
Study Summary
Data were collected from a purposive sample of 105 inpatient postpartum mothers
who gave birth between July 2018 and August 2018 in a 208-bed free-standing women’s
community hospital located in a large Southern California metropolitan area. The mean
age for the combined group was 30.7+5.02 (range 18-46). Mean years of education were
15.22+3.2 and mean previous births was 1+1.06. Comparisons were made between those
scoring <10 on the EPDS or GAD-7, referred to as Group A, and those scoring >10 on
the EPDS or GAD-7, referred to as Group B. Groups A and B were similar in terms of
ethnicity and primary language with 46% of participants in Group A and 43.8% in Group
B self-identified as Hispanic, followed by 32.2% White in Group A and 37.5% White in
Group B. English was the primary language for 73.6% in Group A, and 75% in Group B.
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Approximately two thirds of the 105 participants (69.9%) were married; a higher
percentage of participants in Group A were married (73.6%) as compared to Group B
(50%). This difference was significant (p=.01) and an association between unpartnered
status and depression has been supported in the literature (Ertel et al., 2011).
There were no significant differences between Group A and Group B in terms of
age, education, previous births, language, ethnicity, type of delivery, or planned
pregnancy. Pregnancy was planned for 72.8% of the groups combined with slightly
higher rates (74.7%) in Group A, as compared to 62.5% in Group B (p=.35). An
increased risk of depression with unintended pregnancy has been supported in the
literature; however, this difference may not have been observed in this study as a result of
the sample size (Rich-Edwards et al., 2006). Regarding prior history of depression and
anxiety, 36% of total participants reported some mental health history, 64% reported no
history or no answer. Because it was not possible to determine if no answer indicated no
history or simply no answer, a comparison between groups for history of depression,
anxiety, or other mental health diagnosis was not conducted.
The prevalence of total participants scoring >10 on the EPDS (15%) was
consistent with rates reported in the literature of 11-21.9% (Mayberry et al., 2007; Wisner
et al., 2013). Significant differences were found between Group A and Group B for total
EPDS score and GAD-7 score (p<.001) supporting the frequent comorbid relationship
between depression and anxiety identified in the literature (Wisner et al., 2013).
Significant differences were found between groups for the total City MISS score (p=.002)
as well as the three subscales: internal subscale (p<.001), external subscale, p=.03) and
disclosure subscale (p=.02). Significant positive correlations were also found between

53
EPDS and GAD-7 (p=.01) and between all three City stigma subscales: IS (p=.01), ES
(p=.01), and DS (p=.05). Mean scores for the total MSPSS Scale, MSPSS Significant
Other Subscale, MSPSS Family Subscale, and MSPSS Friends Subscale scores were
significantly different between Group A and Group B, with p values <.001, .003, .003,
and .002 respectively supporting existing literature on the variation in social support with
depressive symptomatology; higher rates of depression are associated with lower levels
of social support (Webster et al., 2011). A number of relations among demographic
variables, depressive symptomatology, stigma, and social support were not significant.
For example, relations among demographic variables and the internal and disclosure
stigma subscales and between EPDS and age, level of education, previous births,
ethnicity, language, marital status, planned pregnancy, and type of delivery were not
significant. Similarly, relations between EPDS and ethnicity, language, marital status,
planned pregnancy, and type of delivery were not significant.
Telephone follow up one month after discharge indicated that 33% of participants
in Group B sought mental health treatment; whereas, 66% in this group had not sought
treatment. The current hospital screening process identified fewer patients at risk for
depression, anxiety and self-harm; the process identified 16% with a history of
depression, anxiety, or other mental health diagnosis, 5% feeling depressed or anxious to
a degree that seemed unusual, and 0.8% with thoughts of self-harm. This was in contrast
to the study findings of 36% with a history of depression, anxiety, or other mental health
diagnosis, 15% with PMAD symptomatology, and 3.8% of participants with thoughts of
self-harm. These differences support the need for screening utilizing a validated
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instrument as recommended by the American College of Obstetricians and Gynecologists
ACOG, 2015).
Nursing Implications
Nursing Practice
The findings of this study add to the body of literature describing the relationships
among depression and anxiety, stigma, and social support. It was notable that the
existing screening process identified far fewer patients than the study screening
instruments supporting existing literature on the benefits of utilizing valid and reliable
screening instruments (ACOG, 2018, Evans et al., 2015). Further examination is needed
regarding the current hospital admission screening process including the timing of
screening, whether the questions are asked when family members are in the room, and the
way the screening is approached. Hospital nurses play a key role as members of the interprofessional team by screening patients for PMADs. Patients should be screened in
private, in a non-judgmental way, when they are not in pain with active labor, and with a
standardized, validated instrument. The ideal instrument will have been validated with
inpatient postpartum women from diverse cultures. When at-risk patients are identified,
nurses are well-suited to educate them on the signs, symptoms, and referral resources for
PMADs and refer them to additional resources such as in-house social workers and
outpatient counseling. Because screening may not occur after discharge or it may not be
conducted in accordance with symptoms, screening and education during the inpatient
stay may be very beneficial. Nurses can help familiarize all patients with signs,
symptoms, and resources for PMADs.

55
Education
Nurses and other health professionals may benefit from ongoing education
regarding PMAD risk factors, screening methodology, referral resources, as well as the
relationships between depression, anxiety, stigma, and social support. Investigators on
the United States Preventive Services Task Force reviewed 50 studies on interventions to
decrease the risk of depression during pregnancy and the postpartum period. One of the
key findings is that counseling can help prevent depression in women at increased risk
(O'Connor, Senger, Henninger, Coppola, & Gaynes, 2019). With a greater understanding
of the relationships between depression, anxiety, stigma, and social support, when
patients are identified at risk for PMAD nurses can help to address the stigma of mental
illness, help to ensure patients have adequate social support, and refer them to appropriate
resources.
Limitations
This study has several limitations. The overall sample size was small, and as a
result, the size of Group B (EPDS and GAD-7>10) was small (n=16). As a result, there
was insufficient power to conduct a logistic regression. The study was also conducted
during 1 month in the summer and may not be representative of other periods during the
year. The demographic survey did not include an option for patients with no mental
health history as compared to participants who did not answer the question. As a result, a
statistical comparison could not be made between participants with a mental health
history and those without. Providing a phone number for treatment-seeking follow-up
was voluntary and because only 10 of the 16 in Group B provided phone numbers, it was
not possible to obtain follow-up information regarding treatment seeking from six of the
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16. Four participants who provided phone numbers could not be reached further limiting
the information that could be obtained about treatment-seeking. Further study is needed
regarding the actual treatment of women with PMADs in relation to their ratings of
stigma and social support.
The sample was limited to English- and Spanish-speaking patients and may not be
representative of individuals from different cultures or who speak other languages. Signs
and symptoms of PMADs can appear at any time during the perinatal period and because
study instruments were administered approximately 24 hours after delivery, EPDS or
GAD-7 scores could be less accurate than if the screening occurred at several intervals
during the postpartum period. For example, a participant with a score >10 on the EPDS
could potentially be experiencing transient depressive symptoms, or a participant with a
score <10 could develop symptoms in the weeks and months post-discharge. In addition,
both the EPDS and GAD-7 are screening instruments and are not diagnostic; therefore,
further evaluation of screened individuals is needed to diagnose depression or anxiety. In
the immediate postpartum period there are many interruptions and participants may have
been fatigued, thus affecting the ratings on the study instruments. The majority of studies
utilizing the EPDS and GAD-7 have been conducted in an outpatient setting, rather than
an inpatient one, and more ideal screening instruments for the immediate postpartum
period are not yet available.
This study did not examine aspects of stigma and social support in depth and to
protect the privacy of participants, personal identifying information was not collected.
As a result, participants’ medical records were not accessed and answers to admission
screening questions were not matched with results from study instruments. To truly

57
examine the concordance of current admission depressive screen and study instruments,
access to participants’ medical records would be required.
Despite the noted limitations, this study adds to the body of knowledge regarding
risk for PMADs in postpartum patients and further clarifies the relationships among
PMAD symptomatology, stigma, and social support. Future research is needed to further
understand the relationships among the stigma of mental illness, social support, PMADs,
and treatment-seeking in postpartum women as well as more research on the specific
dimensions of stigma and interventions to address overcoming barriers to treatment in
this patient population.
Conclusion
The perinatal period is a high-risk period during which as much as 21% of women
may suffer from PMADs and lead to potential adverse effects on the entire family. The
absence or inconsistency of screening and the stigma of mental illness contribute to less
than half of women with PMADs being identified and treated. Strong social support may
mitigate the effects of stigma and may play a significant role in the identification and
treatment of women with PMAD. This study examined the relationships among
demographic variables, PMAD symptomatology, stigma, and social support, and shed
light on barriers to the identification and treatment of women with PMADs. This study
contributes to the nursing profession by highlighting the prevalence of PMADs, impact
on families, ongoing barriers to identification and treatment, and by highlighting gaps in
the existing hospital screening process as compared to screening utilizing valid, reliable
instruments, thereby providing the basis for implementing standardized screening in the
inpatient setting.
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Appendix B
Informed Consent
Study Title: Perinatal Mood and Anxiety Disorders: Impact of Stigma and Social Support on
Treatment-Seeking
Dear Patient:
You are being asked to participate in a research study conducted by Ellen K. Fleischman,
PhD student at the University of San Diego. The purpose of this study is to answer the
following questions: What is the relationship between stigma, perinatal mood and anxiety
disorders (focusing on depression and anxiety), and social support? When mothers suffer
from these disorders, how do stigma and social support affect the decision to seek
treatment for depression and anxiety? Approximately 100 patients on the Maternal Infant
Services Unit will take part in this study at Sharp Mary Birch Hospital for Women &
Newborns.
Your participation in this study involves a one-time completion of several questionnaires:
the 10-question Edinburgh Postnatal Depression Scale (EPDS), 15-question City Mental
Illness Stigma Scale (City MISS), 12-question Multidimensional Measure of Perceived Social
Support (MSPSS), 7-question Generalized Anxiety Disorder Scale (GAD-7), and a
demographic questionnaire. Your participation is expected to last approximately 15-20
minutes. You will be provided with resources related to depression and anxiety in case you
would like further information. If your scores on the study instruments indicate you may
have some difficulty with depression or anxiety we would like to contact you, with your
permission, after discharge, to discuss available resources.
Risks and Benefits: There are no anticipated risks for participating; however, some patients
may feel uncomfortable when answering some of the questions on the surveys, as the
questions may cause you to reflect on your feelings. However, your participation may be of
benefit because the surveys may prompt you to ask some important questions that you
might not have thought of previously and provide more information on your overall
wellness. We will try to make you as comfortable as possible when you are answering the
questions.
Your survey answers will be anonymous and will be identified by a study code known only to
you and the investigator. Your individual responses will not be shared with anyone at Sharp
other than the investigator. Your individual responses will be aggregated with all other
participants in the study. The aggregated data will be analyzed, and results will be shared
with the University of San Diego and Sharp Mary Birch Hospital for Women & Newborns.
Should you choose to have us contact you after discharge, there will be an option to include
your phone number and e-mail address on a separate piece of paper that has your study
code. The person making the discharge phone call will not have access to other information
about you. Representatives of the Sharp HealthCare Institutional Review Board (IRB) may
review the study at any time, (including your de-identified individual responses), to assure
that the study is being carried out appropriately.
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You will be compensated for your time with a $10 gift card upon completion of all surveys. If
you wish to participate, your completion of the surveys will indicate that you have read
this consent, have had a chance to ask questions, and that you consent to participate.
Your participation in this study is completely voluntary, and if you do not wish to
participate, you do not need to do anything further. If you start the surveys and decide
not to finish, you can stop at any time. Please complete the attached surveys and return
them in the attached envelope, either to the investigator or to your nurse.
If you have any questions at any time, please feel free to contact Ellen K. Fleischman at
ellen.fleischman@sharp.com or (858) 939-4174. If you have any questions about your
rights as a participant in research you may contact the Sharp HealthCare Institutional
Review Board (IRB; a group of people who review research to protect the rights of research
participants) at 858-939-7195.
Thank you for your consideration.
Ellen K. Fleischman, MSN, RN, RD, NE-BC
(858) 939-4174, Ellen.fleischman@sharp.com
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